236 related articles for article (PubMed ID: 32822727)
1. The role of small leucine zipper protein in osteoclastogenesis and its involvement in bone remodeling.
Kim S; Park S; Kang M; Ko J
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118827. PubMed ID: 32822727
[TBL] [Abstract][Full Text] [Related]
2. A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation.
Kim J; Ko J
Cell Death Differ; 2014 Oct; 21(10):1642-55. PubMed ID: 24948012
[TBL] [Abstract][Full Text] [Related]
3. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
4. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
5. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
[TBL] [Abstract][Full Text] [Related]
7. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
8. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y
FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934
[TBL] [Abstract][Full Text] [Related]
9. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
[TBL] [Abstract][Full Text] [Related]
10. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
11. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
12. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
[TBL] [Abstract][Full Text] [Related]
13. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
[TBL] [Abstract][Full Text] [Related]
14. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
Liu C; Cao Z; Zhang W; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Tan R; Dong S; Xu J
J Cell Physiol; 2018 Nov; 233(11):8971-8983. PubMed ID: 29904917
[TBL] [Abstract][Full Text] [Related]
15. Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption.
Zhang Y; Zhao L; Wang N; Li J; He F; Li X; Wu S
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988158
[TBL] [Abstract][Full Text] [Related]
16. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
17. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
18. PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation.
Zhao X; Cui P; Hu G; Wang C; Jiang L; Zhao J; Xu J; Zhang X
J Mol Cell Biol; 2020 Jan; 12(1):55-70. PubMed ID: 30986855
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.
David M; Machuca-Gayet I; Kikuta J; Ottewell P; Mima F; Leblanc R; Bonnelye E; Ribeiro J; Holen I; Vales RL; Jurdic P; Chun J; Clézardin P; Ishii M; Peyruchaud O
J Biol Chem; 2014 Mar; 289(10):6551-6564. PubMed ID: 24429286
[TBL] [Abstract][Full Text] [Related]
20. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
